Of note, however, is that a significant fraction of published microarray studies using the AR-dependent prostate cancer cell lines have been performed using high doses of androgen (≥10 nM) (Dehm and Tindall 2006), which induce profound cell cycle arrest in prostate cancer cells. Here, AR is linked to prostate carcinoma.